封面
市場調查報告書
商品編碼
1830757

2025年去氧核糖核酸(DNA)閱讀、寫作和編輯市場報告

Deoxyribonucleic Acid (DNA) Read, Write And Edit Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來,去氧核糖核酸(DNA) 的讀取、寫入和編輯市場迅速擴張,市場規模從 2024 年的 86.5 億美元成長至 2025 年的 101.8 億美元,複合年成長率達 17.7%。過去一段時間的成長與以下因素相關:遺傳疾病的盛行率不斷上升、個人化醫療需求的不斷成長、學術和產業基因組學研究的不斷擴展、次世代定序儀技術的日益普及,以及政府和私人部門對測序基礎設施的投資不斷增加。

去氧核糖核酸(DNA) 的讀取、寫入和編輯市場預計將在未來幾年快速成長,到 2029 年將達到 192.8 億美元,複合年成長率為 17.3%。預測期內的成長可歸因於精準醫療需求的不斷成長、基於 DNA 的數據存儲投資的不斷增加、合成生物學應用的日益普及、DNA 測序服務的不斷擴展以及人們對早期疾病檢測意識的不斷增強。預測期內的主要趨勢包括基因組編輯技術的進步、DNA 合成方法的持續創新、可攜式定序設備的開發、研發的進展以及生物資訊工具的改進。

讀取、寫入和編輯去氧核糖核酸(DNA) 是指一組用於序列測定遺傳訊息(讀取)、合成新的 DNA 鏈(寫入)以及修改現有基因序列(編輯)的技術。這些過程旨在理解遺傳密碼、創造合成基因,並為研究、醫學和生物技術實現精準的基因改造。

DNA讀取、寫入和編輯的主要類別包括套件和試劑、細胞株工程、動物模型和服務。套件和試劑由預包裝的材料和化學品組成,用於執行研究、診斷和生物技術領域的特定實驗室測試、實驗和程序。這些套件和試劑採用各種技術,例如CRISPR、TALEN和鋅指核酸酶,以及各種遞送方法,例如病毒載體、非病毒載體、電穿孔和顯微注射。應用涵蓋基因治療、診斷、生物技術、農業和合成生物學,主要終端用戶包括製藥和生物技術公司、學術研究機構和臨床研究組織。

2025年春季美國突然提高關稅以及由此引發的貿易摩擦對醫療保健產業產生了嚴重影響,特別是對關鍵醫療設備、診斷設備和藥品的供應。醫院和醫療機構面臨進口手術器械、影像設備以及注射器和導管等消耗品成本上漲的問題。這些成本上漲給醫療保健預算帶來了壓力,導致一些醫療機構推遲設備升級或將成本轉嫁給患者。此外,原料和零件的關稅阻礙了基本藥品和醫療設備的生產,造成了供應鏈瓶頸。作為應對措施,該行業正在籌資策略多樣化,盡可能促進本地生產,並倡導對緊急醫療產品免關稅。

這份關於去氧核糖核酸(DNA) 閱讀、寫作和編輯市場統計數據的研究報告,提供了您在去氧核糖核酸(DNA) 閱讀、寫作和編輯行業取得成功所需的數據,包括各地區市場佔有率、競爭對手的市場佔有率、詳細的去氧核糖核酸(去氧核糖核酸) 閱讀、寫作和編輯市場細分、市場趨勢和商業機會。本研究報告全面概​​述了您需要了解的有關去氧核糖核酸(DNA) 閱讀、寫作和編輯市場的所有資訊,並深入分析了該行業的現狀和未來前景。

預計未來幾年,遺傳病患病率的上升將推動去氧核糖核酸(DNA) 讀取、寫入和編輯市場的成長。遺傳疾病是由個體 DNA 異常引起的疾病,異常可能遺傳自父母一方或雙方,也可能由新生突變引起。遺傳疾病的增加與父母年齡的成長有關,因為年長的父母更有可能將基因突變遺傳給他們的孩子。 DNA 讀取、寫入和編輯技術能夠精確檢測、糾正和修改致病基因,從而幫助管理遺傳疾病。這些進步正在透過標靶治療改善醫療保健結果,降低遺傳疾病風險,並為受影響的個人提供個人化醫療。例如,2024 年 5 月,英國國家醫療服務體系 (NHS) 報告稱,有 17,000 人患有鐮狀細胞疾病(一種遺傳性血液疾病),每年約有 250 例新診斷病例。因此,遺傳病患病率的上升正在刺激 DNA 讀取、寫入和編輯市場的擴張。

DNA讀取、編寫和編輯市場的公司正專注於開發尖端產品,例如高品質、合規的合成DNA,以加快研究速度、確保安全性並加速尖端療法的商業化。合規的合成DNA是指人工生產的DNA,其精確、無污染且符合安全和法律標準,適用於研究、診斷和治療應用。例如,2022年5月,美國生技公司GenScript Inc.推出了GenExact(GMP單鏈DNA)和GenWand(GMP封閉式封閉式雙鏈DNA)服務。這些服務支持從研發到新藥臨床實驗試驗(IND)申請和臨床試驗的快速過渡,為更安全、更有效率的CRISPR非病毒基因插入提供高品質、非病毒的同源性定向修復(HDR)模板,用於先進的細胞和基因療法。 DNA 在專門的 cGMP 設施中生產,具有完整的文件和法規遵從性,並經過嚴格的測試以確保身份、純度、效力和安全性,為治療目的提供可靠且可擴展的遺傳材料來源。

2023年1月,荷蘭生技公司Qiagen NV收購了Verogen Inc.,收購金額未揭露。此次收購增強了Qiagen在DNA讀取、寫入和編輯技術方面的能力,並鞏固了其在法醫學基因組學和分子診斷市場的地位。 Verogen Inc.是一家總部位於美國的生物技術公司,專注於DNA讀取、寫入和編輯技術。

去氧核糖核酸(DNA) 讀取、寫入和編輯市場由提供基因檢測服務、基因序列測定服務、基因編輯服務、合成生物學服務和生物資訊分析服務等服務的營業單位所獲得的收益組成。市場價值還包括服務供應商銷售的或包含在其服務產品中的相關商品的價值。去氧核糖核酸(DNA) 讀取、寫入和編輯市場還包括去氧核糖核酸(DNA) 定序儀、基因合成試劑套件、基因組編輯工具和生物資訊軟體的銷售。該市場的價值是「工廠門口」價值,即商品製造商或創造者出售給其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接出售給最終客戶的商品價值。該市場中的商品價值還包括商品創造者出售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場:宏觀經濟情景,包括利率、通膨、地緣政治、貿易戰和關稅,以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球去氧核糖核酸(DNA)閱讀、寫作、編輯:PESTEL分析(政治、社會、技術、環境、法律因素、促進因素和限制因素)
  • 最終用途產業分析
  • 全球去氧核糖核酸(DNA)讀取、寫入和編輯市場:成長率分析
  • 全球去氧核糖核酸(DNA) 閱讀、寫作和編輯市場表現:規模與成長,2019-2024 年
  • 全球去氧核糖核酸(DNA) 閱讀、寫作和編輯市場預測:規模與成長,2024-2029 年,2034 年
  • 全球去氧核糖核酸(DNA) 閱讀、寫作和編輯:總潛在市場 (TAM)

第6章 市場細分

  • 全球去氧核糖核酸(DNA) 閱讀、寫作和編輯市場類型、表現及預測(2019-2024 年、2024-2029 年、2034 年)
  • 套件和試劑
  • 細胞株工程
  • 動物模型
  • 服務
  • 全球去氧核糖核酸(DNA) 讀取、寫入和編輯市場(按技術、性能和預測),2019-2024 年、2024-2029 年、2034 年
  • 叢集規律間隔短回文重複序列 (CRISPR)
  • 轉錄活化因子(例如效應核酸酶)(Talen)
  • 鋅指核酸酶
  • 其他技術
  • 全球去氧核糖核酸(DNA) 閱讀、寫作和編輯市場(按交付方式、表現和預測),2019-2024 年、2024-2029 年、2034 年
  • 病毒載體
  • 非病毒載體
  • 電穿孔
  • 顯微注射
  • 全球去氧核糖核酸(DNA)讀取、寫入和編輯市場的應用、性能和預測,2019-2024年、2024-2029年、2034年
  • 基因治療
  • 診斷
  • 生物技術
  • 農業
  • 合成生物學
  • 全球去氧核糖核酸(DNA) 閱讀、書寫和編輯市場(按最終用戶、表現和預測),2019-2024 年、2024-2029 年、2034 年
  • 製藥和生物技術公司
  • 學術研究機構
  • 臨床研究所
  • 全球去氧核糖核酸(DNA) 讀取、寫入和編輯市場:細分試劑套件和試劑(按類型)、性能和預測,2019-2024 年、2024-2029 年、2034 年
  • 去氧核糖核酸套件(DNA套件)
  • 核糖核酸試劑套件(RNA試劑套件)
  • 蛋白質測定試劑套件(PA套件)
  • 基因編輯試劑(GER)
  • 聚合酵素鏈鎖反應試劑(PCR試劑)
  • 全球去氧核糖核酸(DNA) 讀取、寫入和編輯市場:細分細胞株工程(按類型)、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 穩定細胞株(SCL)
  • 瞬時細胞株(TCL)
  • 融合瘤細胞株(HCL)
  • 報告細胞株(RCL)
  • 初代細胞株(PCL)
  • 全球去氧核糖核酸(DNA) 閱讀、寫作和編輯市場:按動物模型細分(按類型)、表現和預測,2019-2024 年、2024-2029 年、2034 年
  • 基因改造動物(TA)
  • 基因敲除動物(KA)
  • 人源化動物(HA)
  • 異種移植模型(XM)
  • 近交系(IS)
  • 全球去氧核糖核酸(DNA) 閱讀、寫作和編輯市場:按服務類型、表現和預測細分,2019-2024 年、2024-2029 年、2034 年
  • 客製化基因編輯(CGE)
  • 細胞株開發(CLD)
  • 動物模型開發(AMD)
  • 分析測試服務(ATS)
  • 諮詢服務(CS)

第7章 區域和國家分析

  • 全球去氧核糖核酸(DNA) 閱讀、寫作和編輯市場:2019-2024 年、2024-2029 年和 2034 年區域表現和預測
  • 全球去氧核糖核酸(DNA) 閱讀、寫作和編輯市場:國家、績效與預測,2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章:中國市場

第10章 印度市場

第11章 日本市場

第12章:澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章:西歐市場

第16章英國市場

第17章:德國市場

第18章:法國市場

第19章:義大利市場

第20章:西班牙市場

第21章 東歐市場

第22章:俄羅斯市場

第23章 北美市場

第24章美國市場

第25章:加拿大市場

第26章 南美洲市場

第27章:巴西市場

第28章 中東市場

第29章:非洲市場

第30章:競爭格局與公司概況

  • 去氧核糖核酸(DNA)閱讀、寫作和編輯市場:競爭格局
  • 去氧核糖核酸(DNA)閱讀、寫作和編輯市場:公司簡介
    • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章:其他領先和創新企業

  • MGI Tech
  • Bio-Rad Laboratories Inc.
  • BGI Group
  • Ginkgo Bioworks
  • Oxford Nanopore Technologies
  • Twist Bioscience Corporation
  • New England Biolabs
  • GenScript Biotech Corporation
  • Pacific Biosciences
  • Beam Therapeutics Inc.
  • Prime Medicine
  • Editas Medicine Inc.
  • Cellectis SA
  • 3Billion Inc.
  • CRISPR Therapeutics AG

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章:高潛力市場國家、細分市場與策略

  • 2029年去氧核糖核酸(DNA)閱讀、寫作和編輯市場:提供新機會的國家
  • 2029年去氧核糖核酸(DNA)讀取、寫入和編輯市場:細分領域帶來新機會
  • 去氧核糖核酸(DNA)閱讀、寫作和編輯市場2029年:成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r37745

Deoxyribonucleic acid (DNA) reading, writing, and editing refer to a set of techniques used to sequence (read) genetic information, synthesize (write) new DNA strands, and modify (edit) existing genetic sequences. These processes aim to understand the genetic code, create synthetic genes, and enable precise genetic modifications for research, medicine, and biotechnology.

The primary categories of DNA reading, writing, and editing include kits and reagents, cell line engineering, animal models, and services. Kits and reagents consist of pre-packaged materials and chemical substances designed to perform specific laboratory tests, experiments, or procedures in research, diagnostics, and biotechnology. These utilize various technologies such as clustered regularly interspaced short palindromic repeats (CRISPR), transcription activator-like effector nucleases (TALEN), zinc finger nucleases, and others, with different delivery methods such as viral vectors, non-viral vectors, electroporation, and microinjection. Their applications cover gene therapy, diagnostics, biotechnology, agriculture, and synthetic biology, with major end users including pharmaceutical and biotechnology companies, academic and research institutions, and clinical research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The deoxyribonucleic acid (DNA) read, write, and edit market research report is one of a series of new reports from The Business Research Company that provides deoxyribonucleic acid (DNA) read, write, and edit market statistics, including the deoxyribonucleic acid (DNA) read, write, and edit industry global market size, regional shares, competitors with the deoxyribonucleic acid (DNA) read, write, and edit market share, detailed deoxyribonucleic acid (DNA) read, write, and edit market segments, market trends, and opportunities, and any further data you may need to thrive in the deoxyribonucleic acid (DNA) read, write, and edit industry. This deoxyribonucleic acid (DNA) read, write, and edit market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The deoxyribonucleic acid (DNA) read, write, and edit market size has grown rapidly in recent years. It will grow from $8.65 billion in 2024 to $10.18 billion in 2025 at a compound annual growth rate (CAGR) of 17.7%. Growth during the historical period can be linked to the increasing prevalence of genetic disorders, the rising demand for personalized medicine, the expansion of academic and industrial genomics research, the growing adoption of next-generation sequencing, and the rise in government and private investments in sequencing infrastructure.

The deoxyribonucleic acid (DNA) read, write, and edit market size is expected to see rapid growth in the next few years. It will grow to $19.28 billion in 2029 at a compound annual growth rate (CAGR) of 17.3%. Growth in the forecast period can be attributed to the increasing demand for precision medicine, greater investment in DNA-based data storage, the rising adoption of synthetic biology, the expansion of DNA sequencing services, and heightened awareness of early disease detection. Key trends expected during the forecast period include technological progress in genome editing, continuous innovation in DNA synthesis methods, the development of portable sequencing devices, advancements in research and development, and improvements in bioinformatics tools.

The rising prevalence of genetic disorders is expected to drive the growth of the deoxyribonucleic acid (DNA) read, write, and edit market in the coming years. Genetic disorders are medical conditions caused by abnormalities in an individual's DNA, either inherited from one or both parents or resulting from new mutations. The increase in genetic disorders is linked to the rise in parental age, as older parents have a greater likelihood of passing genetic mutations to their children. DNA reading, writing, and editing technologies help manage genetic disorders by enabling accurate detection, correction, and modification of disease-causing genes. These advancements improve healthcare outcomes through targeted therapies, lowering the risk of inherited conditions, and advancing personalized medicine for affected individuals. For example, in May 2024, the National Health Service, a UK-based government department, reported that 17,000 people are living with sickle cell disease, an inherited genetic blood disorder, with approximately 250 new cases diagnosed annually. Therefore, the growing prevalence of genetic disorders is fueling the expansion of the DNA read, write, and edit market.

Companies in the DNA read, write, and edit market are emphasizing the development of advanced products, such as high-quality, regulatory-compliant synthetic DNA, to speed up research, ensure safety, and facilitate the commercialization of advanced therapies. Regulatory-compliant synthetic DNA refers to artificially produced DNA that is accurate, free from contaminants, and manufactured according to safety and legal standards, making it suitable for research, diagnostics, and therapeutic use. For instance, in May 2022, GenScript Inc., a US-based biotechnology company, introduced GenExact (GMP single-stranded DNA) and GenWand (GMP closed-end linear double-stranded DNA) services. These offerings support faster transitions from research and development to investigational new drug (IND) submissions and clinical trials by providing high-quality, non-viral homology-directed repair (HDR) templates, which enable safer and more efficient CRISPR non-viral gene insertion for advanced cell and gene therapies. The DNA is produced in specialized cGMP facilities, comes with full documentation and regulatory compliance, and undergoes rigorous testing to ensure identity, purity, potency, and safety, delivering a reliable and scalable source of genetic material for therapeutic purposes.

In January 2023, Qiagen N.V., a biotechnology company based in the Netherlands, acquired Verogen Inc. for an undisclosed amount. This acquisition enhanced Qiagen's capabilities in DNA read, write, and edit technologies, strengthening its position in forensic genomics and molecular diagnostics markets. Verogen Inc. is a US-based biotechnology company specializing in DNA read, write, and edit technologies.

Major players in the deoxyribonucleic acid (DNA) read, write and edit market are Roche Holding AG, Bayer AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., MGI Tech, Bio-Rad Laboratories Inc., BGI Group, Ginkgo Bioworks, Oxford Nanopore Technologies, Twist Bioscience Corporation, New England Biolabs, GenScript Biotech Corporation, Pacific Biosciences, Beam Therapeutics Inc., Prime Medicine, Editas Medicine Inc., Cellectis S.A., 3Billion Inc., and CRISPR Therapeutics AG.

North America was the largest region in the deoxyribonucleic acid (DNA) read, write and edit market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in deoxyribonucleic acid (DNA) read, write and edit market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the deoxyribonucleic acid (DNA) read, write and edit market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The deoxyribonucleic acid (DNA) read, write and edit market consists of revenues earned by entities by providing services such as genetic testing services, genome sequencing services, gene editing services, synthetic biology services, and bioinformatics analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The deoxyribonucleic acid (DNA) read, write and edit market also includes sales of deoxyribonucleic acid (DNA) sequencers, gene synthesis kits, genome editing tools, and bioinformatics software. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Deoxyribonucleic Acid (DNA) Read, Write And Edit Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on deoxyribonucleic acid (dna) read, write and edit market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for deoxyribonucleic acid (dna) read, write and edit ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The deoxyribonucleic acid (dna) read, write and edit market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Types: Kits And Reagents; Cell Line Engineering; Animal Models; Services
  • 2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR); Transcription Activator-Like Effector Nucleases (Talen); Zinc Finger Nucleases; Other Technologies
  • 3) By Delivery Mode: Viral Vectors; Non-Viral Vectors; Electroporation; Microinjection
  • 4) By Application: Gene Therapy; Diagnostics; Biotechnology; Agricultural; Synthetic Biology
  • 5) By End Users: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Clinical Research Organizations
  • Subsegments:
  • 1) By Kits And Reagents: Deoxyribonucleic Acid Kits (DNA Kits); Ribonucleic Acid Kits (RNA Kits); Protein Assay Kits (PA Kits); Gene Editing Reagents (GER); Polymerase Chain Reaction Reagents (PCR Reagents)
  • 2) By Cell Line Engineering: Stable Cell Lines (SCL); Transient Cell Lines (TCL); Hybridoma Cell Lines (HCL); Reporter Cell Lines (RCL); Primary Cell Lines (PCL)
  • 3) By Animal Models: Transgenic Animals (TA); Knockout Animals (KA); Humanized Animals (HA); Xenograft Models (XM); Inbred Strains (IS)
  • 4) By Services: Custom Gene Editing (CGE); Cell Line Development (CLD); Animal Model Development (AMD); Analytical Testing Services (ATS); Consulting Services (CS)
  • Companies Mentioned: Roche Holding AG; Bayer AG; Thermo Fisher Scientific Inc.; Danaher Corporation; Agilent Technologies Inc.; MGI Tech; Bio-Rad Laboratories Inc.; BGI Group; Ginkgo Bioworks; Oxford Nanopore Technologies; Twist Bioscience Corporation; New England Biolabs; GenScript Biotech Corporation; Pacific Biosciences; Beam Therapeutics Inc.; Prime Medicine; Editas Medicine Inc.; Cellectis S.A.; 3Billion Inc.; CRISPR Therapeutics AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Characteristics

3. Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Trends And Strategies

4. Deoxyribonucleic Acid (DNA) Read, Write And Edit Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Growth Rate Analysis
  • 5.4. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Total Addressable Market (TAM)

6. Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Segmentation

  • 6.1. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kits And Reagents
  • Cell Line Engineering
  • Animal Models
  • Services
  • 6.2. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
  • Transcription Activator-such as Effector Nucleases (Talen)
  • Zinc Finger Nucleases
  • Other Technologies
  • 6.3. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Viral Vectors
  • Non-Viral Vectors
  • Electroporation
  • Microinjection
  • 6.4. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gene Therapy
  • Diagnostics
  • Biotechnology
  • Agricultural
  • Synthetic Biology
  • 6.5. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Academic And Research Institutes
  • Clinical Research Organizations
  • 6.6. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deoxyribonucleic Acid Kits (DNA Kits)
  • Ribonucleic Acid Kits (RNA Kits)
  • Protein Assay Kits (PA Kits)
  • Gene Editing Reagents (GER)
  • Polymerase Chain Reaction Reagents (PCR Reagents)
  • 6.7. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Sub-Segmentation Of Cell Line Engineering, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stable Cell Lines (SCL)
  • Transient Cell Lines (TCL)
  • Hybridoma Cell Lines (HCL)
  • Reporter Cell Lines (RCL)
  • Primary Cell Lines (PCL)
  • 6.8. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Sub-Segmentation Of Animal Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transgenic Animals (TA)
  • Knockout Animals (KA)
  • Humanized Animals (HA)
  • Xenograft Models (XM)
  • Inbred Strains (IS)
  • 6.9. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Custom Gene Editing (CGE)
  • Cell Line Development (CLD)
  • Animal Model Development (AMD)
  • Analytical Testing Services (ATS)
  • Consulting Services (CS)

7. Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Regional And Country Analysis

  • 7.1. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 8.1. Asia-Pacific Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 9.1. China Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Overview
  • 9.2. China Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 10.1. India Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 11.1. Japan Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Overview
  • 11.2. Japan Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 12.1. Australia Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 13.1. Indonesia Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 14.1. South Korea Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Overview
  • 14.2. South Korea Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 15.1. Western Europe Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Overview
  • 15.2. Western Europe Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 16.1. UK Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 17.1. Germany Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 18.1. France Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 19.1. Italy Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 20.1. Spain Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 21.1. Eastern Europe Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Overview
  • 21.2. Eastern Europe Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 22.1. Russia Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 23.1. North America Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Overview
  • 23.2. North America Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 24.1. USA Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Overview
  • 24.2. USA Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 25.1. Canada Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Overview
  • 25.2. Canada Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 26.1. South America Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Overview
  • 26.2. South America Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 27.1. Brazil Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 28.1. Middle East Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Overview
  • 28.2. Middle East Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

  • 29.1. Africa Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Overview
  • 29.2. Africa Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Deoxyribonucleic Acid (DNA) Read, Write And Edit Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Competitive Landscape And Company Profiles

  • 30.1. Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Competitive Landscape
  • 30.2. Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Company Profiles
    • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Other Major And Innovative Companies

  • 31.1. MGI Tech
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. BGI Group
  • 31.4. Ginkgo Bioworks
  • 31.5. Oxford Nanopore Technologies
  • 31.6. Twist Bioscience Corporation
  • 31.7. New England Biolabs
  • 31.8. GenScript Biotech Corporation
  • 31.9. Pacific Biosciences
  • 31.10. Beam Therapeutics Inc.
  • 31.11. Prime Medicine
  • 31.12. Editas Medicine Inc.
  • 31.13. Cellectis S.A.
  • 31.14. 3Billion Inc.
  • 31.15. CRISPR Therapeutics AG

32. Global Deoxyribonucleic Acid (DNA) Read, Write And Edit Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

34. Recent Developments In The Deoxyribonucleic Acid (DNA) Read, Write And Edit Market

35. Deoxyribonucleic Acid (DNA) Read, Write And Edit Market High Potential Countries, Segments and Strategies

  • 35.1 Deoxyribonucleic Acid (DNA) Read, Write And Edit Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Deoxyribonucleic Acid (DNA) Read, Write And Edit Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Deoxyribonucleic Acid (DNA) Read, Write And Edit Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer